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Abstract
Background: The CE-MARC study assessed the diagnostic performance investigated the use of cardiovascular magnetic
resonance (CMR) in patients with suspected coronary artery disease (CAD). The study used a multi-parametric CMR
protocol assessing 4 components: i) left ventricular function; ii) myocardial perfusion; iii) viability (late gadolinium
enhancement (LGE)) and iv) coronary magnetic resonance angiography (MRA). In this pre-specified CE-MARC
sub-study we assessed the diagnostic accuracy of the individual CMR components and their combinations.
Methods: All patients from the CE-MARC population (n = 752) were included using data from the original blinded-read.
The four individual core components of the CMR protocol was determined separately and then in paired and triplet
combinations. Results were then compared to the full multi-parametric protocol.
Results: CMR and X-ray angiography results were available in 676 patients. The maximum sensitivity for the detection
of significant CAD by CMR was achieved when all four components were used (86.5 %). Specificity of perfusion
(91.8 %), function (93.7 %) and LGE (95.8 %) on its own was significantly better than specificity of the multi-parametric
protocol (83.4 %) (all P < 0.0001) but with the penalty of decreased sensitivity (86.5 % vs. 76.9 %, 47.4 % and 40.8 %
respectively). The full multi-parametric protocol was the optimum to rule-out significant CAD (Likelihood Ratio negative
(LR-) 0.16) and the LGE component alone was the best to rue-in CAD (LR+ 9.81). Overall diagnostic accuracy was similar
with the full multi-parametric protocol (85.9 %) compared to paired and triplet combinations. The use of coronary MRA
within the full multi-parametric protocol had no additional diagnostic benefit compared to the perfusion/function/LGE
combination (overall accuracy 84.6 % vs. 84.2 % (P = 0.5316); LR- 0.16 vs. 0.21; LR+ 5.21 vs. 5.77).
Conclusions: From this pre-specified sub-analysis of the CE-MARC study, the full multi-parametric protocol had the
highest sensitivity and was the optimal approach to rule-out significant CAD. The LGE component alone was the
optimal rule-in strategy. Finally the inclusion of coronary MRA provided no additional benefit when compared to
the combination of perfusion/function/LGE.
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Background
Coronary artery disease (CAD) is a leading cause of
death and disability worldwide. Cardiovascular magnetic
resonance (CMR) is recognised in international guide-
lines as a non-invasive imaging option for the investiga-
tion of suspected CAD [1–3]. The CE-MARC study was
the largest prospective evaluation of the diagnostic ac-
curacy of CMR in stable CAD to date [4, 5]. The trial
adopted a multi-parametric CMR protocol assessing left
ventricular (LV) function, myocardial perfusion, viability
and coronary artery anatomy in a single study. A rigor-
ous study design avoided referral bias by mandating that
all patients underwent X-ray coronary angiography
(XRA) as the reference test independent of the result of
the CMR or single-photon emission computed tomog-
raphy (SPECT) scans. The results from CE-MARC and
its sub-analyses have shown that CMR had high diagnos-
tic accuracy for suspected CAD in males and females, in
single and multi-vessel disease, had higher overall
diagnostic accuracy and was also cost effective compared
to SPECT [6, 7].
Previous studies designed to determine the diagnostic
accuracy of the individual components of the CMR
examination have been small and revealed contrasting
results. Some have shown the full multi-parametric
approach had higher diagnostic accuracy over the
individual components of the combined examination,
although these were performed in selected populations
[8–11]. Furthermore the clinical utility of imaging cor-
onary artery anatomy for the detection of stenosis by
magnetic resonance angiography (MRA) within already
lengthy protocols remains to be established. Klein et al.
demonstrated that MRA at 1.5 Tesla (T) did not add to
the diagnostic accuracy over perfusion and late gadolin-
ium enhancement (LGE) [11]. Other investigators have
evaluated the effect of adding coronary MRA to stress
perfusion and LGE on diagnostic performance in the
intermediate to high risk group; when compared to
invasive pressure-wire derived fractional flow reserve
(FFR) at 1.5 T there was no significant improvement in
diagnostic accuracy [12].
This predefined sub-study of CE-MARC compared the
diagnostic accuracy of the full multi-parametric CMR
protocol with the individual components, and their
paired and triplet combinations. The aim was to deter-
mine the diagnostic accuracy of the individual compo-
nents and their combinations in a large, prospective,




CE-MARC was a prospective study of 752 consecutive
patients with suspected angina and at least one
cardiovascular risk factor. Screening and recruitment
occurred between March 2006 and August 2009 [4, 5].
All patients were scheduled to undergo SPECT and
CMR (in randomized order), followed by XRA within
4 weeks. Inclusion and exclusion criteria have been
previously published [4, 5]. Patients provided informed
written consent and the study was approved by the
local Research Ethics Committee and complied with
the Declaration of Helsinki (2000).
All patients from the CE-MARC population were in-
cluded in this pre-specified sub-analysis. CMR results
were from the original, blinded visual read. The diagnos-
tic accuracy of each individual core component of the
multi-parametric CMR protocol (perfusion, LV function,
MRA and LGE) was determined separately and then in
paired or triplet combinations. The results were com-
pared with the full multi-parametric protocol.
CMR and analysis
The multi-parametric CMR (1.5-Tesla Intera CV,
Philips, Best, The Netherlands) protocol and pulse
sequence parameters have previously been described
[4, 5]. The primary analysis used all four components
of the multi-parametric CMR study. Criteria for a posi-
tive CMR result was any of the following: a) regional
wall motion abnormality (RWMA) on cine imaging;
b) hypoperfusion on stress/rest perfusion imaging;
c) significant stenosis on MRA; d) infarct on LGE
images (Table 1) following a ‘believe the positive rule’.
Individual component image quality scores for CMR
(cines, perfusion, LGE, MRA) were graded 1 (unusable)
to 4 (excellent).
X-ray angiography
XRA images were analysed by two experienced cardiolo-
gists blinded to the CMR and SPECT results. Significant
CAD was defined as ≥70 % stenosis of a first order cor-
onary artery measuring ≥2 mm in diameter, or left main
stem stenosis ≥50 % by quantitative coronary angiog-
raphy (QCA) (QCAPlus, Sanders Data Systems, Palo
Alto, California, USA).
Statistical analysis
Statistical analyses were performed by the Clinical Trials
Research Unit, University of Leeds. Confidence intervals
for the sensitivity, specificity, overall accuracy and posi-
tive (PPV) and negative predictive values (NPV) were
calculated with the Wilson score method. Sensitivities
and specificities were compared by the McNemar’s test,
and predictive values were compared using the general-
ised score statistic. The positive (LR+) and negative like-
lihood ratios (LR-) were calculated using standard
methods [13]. Assessment of the value of each compo-
nent as “add on tests” were made with relative likelihood
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ratios [13]. Statistical analysis performed using with SAS




Both CMR and XRA were available in 676 patients
(mean 60 ± 9.5 years, 62 % male). For the individual
components LGE was available in 674 (99.7 %), perfu-
sion in 661 (97.8 %), ventricular function in 676 (100 %)
and MRA in 597 (88.3 %). The prevalence of XRA
defined significant CAD was 39 % and further demo-
graphic details are shown in Table 2.
Diagnostic accuracy
The sensitivity of the combined CMR protocol was
86.5 % (95 % CI: 81.9–90.1), specificity 83.4 %
(79.5–86.7), PPV 77.2 % (72.1–81.6 %), NPV 90.5 %
(87.1–93.0) and overall diagnostic accuracy 84.6 %
(81.7–87.1). The diagnostic accuracy of the individual
components, paired and triplet combinations compared
to the full multi-parametric protocol are presented in
Table 3 and Fig. 1.
We have shown that of the individual components,
perfusion had numerically the highest sensitivity
(76.9 %), NPV (86.0 %) and overall diagnostic accuracy
(85.9 %), whilst LGE had the highest specificity (95.8 %)
and PPV (86.4 %) for the detection of significant CAD.
The maximum sensitivity (86.5 %) and NPV (90.5 %)
for the detection of significant CAD by CMR was
achieved when the full multi-parametric protocol was
used, no individual component, paired or triplet combin-
ation outperformed the full multi-parametric protocol.
However its lower specificity and PPV, meant that its
overall diagnostic accuracy (84.6 %) was broadly similar
to the majority of paired and triplet combinations
(Table 3).
In terms of specificity, the individual components of
perfusion (91.8 %), ventricular function (93.7 %) and
LGE (95.8 %) all performed significantly better than the
multi-parametric protocol (83.4 %) (P < 0.0001 for all).
In addition, combining LGE with either ventricular
function (91.7 %) or MRA (90.0 %) significantly
improved the test specificity compared to the multi-
parametric protocol (P < 0.0001 for each). For overall
diagnostic performance, no individual component or
combination was better statistically than the full multi-
parametric protocol (Table 3). The use of coronary
MRA had no additional diagnostic benefit in terms of
overall diagnostic accuracy when performed within a
multi-parametric protocol (84.6 % Vs. 84.2 %) (X2 =
0.3913,1df, P = 0.5316).
The value of components as individual and add on tests:
likelihood ratios
The highest likelihood ratio positive (LR+) was
achieved when using LGE imaging alone (LR+ 9.81)
signifying this individual component as the best ap-
proach for ruling in a diagnosis. All individual, paired
and triplet combinations had higher LR+ than the full
multi-parametric protocol (Table 4). However the full
multi-parametric protocol had the lowest LR- (0.16)
than all of the individual components and their combi-
nations, signifying this as the best approach to rule out
significant CAD. The absolute likelihood ratios for all
of the components and their combinations are dis-
played in Table 4. Table 5 illustrates relative likelihood
ratios using selected components as “add-on” tests to
Table 1 Criteria for a positive CMR result in the CE-MARC study
Parameter Method Positive criteria
RWMA Wall motion in each segment (17-segment model)
was visually graded on post-stress cine imaging
[0 = normal, 1 =mild-moderate hypokinesis,
2 = severe hypokinesis, 3 = akinesis, 4 = dyskinesis]
Wall motion Score ≥1 in two or more adjacent
segments, or ≥2 in one or more segments
Ischemia Perfusion in each segment (17-segment model)a
was visually graded at rest and then stress
[0 = normal, 1 = equivocal, 2 = subendocardial
defect, 3 = transmural defect, 4 = transmural
defect and wall thinned]
Decrease in perfusion score ≥2 between rest
and stress in any segment, or ≥1 in each of
two adjacent segmentsb
Stenosis Percentage of coronary artery luminal narrowing
visually assessed on MRA
≥70 % stenosis or ≥50 % left main stem stenosis
Infarction LGE images were visually assessed for
hyper-enhancement in each segment
(17-segment model) [0 = none, 1 = 1–25 %,
2 = 26–50 %, 3 = 51–75 %, 4= > 75 %]
Any score ≥1 in a pattern consistent with
myocardial infarction
RWMA regional wall motion abnormality, MRA magnetic resonance coronary angiography, LGE late-gadolinium enhancement
a17-segment model excluding apical cap
bWith the exception of change between ‘normal’ and ‘equivocal’, which was coded as ‘normal’
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stress perfusion imaging alone, and the absolute num-
ber of new true and false positives cases produced with
each combination.
Discussion
This pre-specified sub-study of the CE-MARC study has
demonstrated the diagnostic accuracy of the individual
components and the paired and triplet combinations
from the multi-parametric CMR examination. The three
main findings were that i) no individual component or
combination of components outperformed the full
multi-parametric protocol to rule out significant coron-
ary artery disease; ii) the LGE component has the best
performance to rule-in significant CAD; and iii) the
addition of MRA to function/perfusion/LGE does not
offer any incremental benefit.
Likelihood ratios
We have shown the absolute likelihood ratio (LR) for
each component and their combinations (Table 4) and
demonstrated how many more (or less) times a particu-
lar component or combination result is likely in patients
with CAD compared to those without the disease. LR is
defined as the ratio of the expected test results in sub-
jects with a certain disease to the subjects without
disease, and they directly link the pre-test and post-test
probability of the disease. A likelihood ratio of greater
than 1 is associated with the presence of disease,
whereas a ratio of less than 1 would indicate the test re-
sult is associated with the absence of disease. Import-
antly, as likelihood ratios are based on the ratio of
sensitivity and specificity of an individual test, they are
independent of disease prevalence, and can therefore be
applied to different populations. The presented LRs can
therefore be applied directly at the individual level and
used to calculate how the probability of having CAD
changes after the result of an individual component or
combination of components of the CMR examination.
Positive and negative likelihood ratios are therefore
useful to understand the role of a test result in changing
a clinician’s estimate of the probability of disease in a
patient.
The LR for positive tests (LR+) is the likelihood
that a given test result would be expected in a patient
with the disease (i.e., how much more likely the posi-
tive test result is to occur in subjects with the disease
compared to those without the disease). LR+ is the
best indicator for a rule-in diagnosis and the higher
the LR+ the more indicative of disease. LR+ is calcu-
lated as follows: LR+ = sensitivity/(1 – specificity).
Therefore high sensitivity and specificity result in high
LR+. The individual components of LGE (LR+ 9.81)
and perfusion (9.35) had the highest LR+ amongst all
the individual components and combinations with
LGE benefitting from very high specificity to overcome
poor sensitivity, and perfusion benefitting from both
high sensitivity and specificity. For both components
tested in isolation, a positive test finding increased the
Table 2 Summary of demographic and angiographic
characteristics
n = 676
Age (years) 60.3 ± 9.5
Male gender 421 (62 %)
Body Mass Index (kg/m2) 29.0 ± 4.3
Ethnicity White 643 (95 %)
Black 5 (1 %)
Asian 24 (4 %)
Other 4 (1 %)
Smoking status Never smoked 236 (35 %)
Ex-smoker 315 (47 %)
Current smoker 125 (18 %)
Systolic Blood Pressure (mmHg) 138.1 ± 20.9
Diastolic Blood Pressure (mmHg) 79.0 ± 11.3
Previous admission for AMI or ACS 54 (8.0 %)
Previous PCI 37 (5 %)
Hypertension 347 (51 %)
Diabetes mellitus 85 (13 %)
Type I 4 (5 %)
Type II 81 (95 %)
Family history of premature CAD Yes 392 (58 %)
No 237 (35 %)
Unknown 47 (7 %)
Total cholesterol (mmol/L) 5.2 (1.2)
Medication
Aspirin and/or Clopidogrel 404 (60 %)
Statin 301 (45 %)
ACEi/A2 Receptor Blockers 229 (37.2 %)
Beta-blocker 203 (33.0 %)
Patients undergoing X-ray angiography
Any significant stenosis 266 (39 %)
Triple Vessel Disease 40 (6 %)
Double Vessel Disease 83 (12 %)
Single Vessel Disease 143 (21 %)
LMS Disease 22 (3 %)
LAD Disease 169 (25 %)
LCx Disease 126 (19 %)
RCA Disease 105 (16 %)
Mean ± standard deviation. Number (percentage)
AMI acute myocardial infarction, ACS acute coronary syndrome, PCI
percutaneous coronary intervention, CAD coronary artery disease, ACEi
angiotensin converting enzyme inhibitor, A2 angiotensin 2, LMS left main
stem, LAD left anterior descending, LCx left circumflex, RCA right
coronary artery
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odds of the patient having CAD more than 9 fold.
Therefore a positive LGE or perfusion test is a good
test for ruling in the diagnosis of CAD.
Likelihood ratios for negative tests (LR-) demonstrate
how much less likely the negative result will occur in
subjects with the disease to the probability that the same
result will occur without the disease. LR- is calculated as
follows: LR- = (1 – specificity)/sensitivity and is a good
indicator for ruling-out the diagnosis. For a single com-
ponent, perfusion imaging produced the smallest likeli-
hood ratio of disease for a negative finding (LR- 0.25):
i.e., the odds of a patient having CAD were reduced by
75 % to one quarter of the pre-test odds with a normal
perfusion result. By comparison, the odds of having
CAD were only reduced by around 40 % with a negative
LGE finding (LR- 0.62). Therefore for a single compo-
nent, perfusion resulted in the greatest change in post-
test odds of having coronary disease, and an overall
diagnostic accuracy of 85.9 %. In terms of both positive
and negative likelihood ratios, no paired or triplet
combination offered a significant benefit over the best
performing component of perfusion alone.
When combining the information from the four compo-
nents in the full multi-parametric protocol using the
“believe the positive” rule, the consequent reductions in
specificity were not met by similar increases in sensitivity,
which resulted in a comparatively low LR+ of 5.21. The
full multi-parametric CMR examination, however, with all
4 components combined had the lowest LR- (0.16) indi-
cating that the combination of all 4 components was best
for ruling out CAD.
The high LR+, low LR- and high overall diagnostic ac-
curacy of the single perfusion component demonstrates
that perfusion imaging ought to have most influence on
a physician's risk stratification of the patients’ likelihood
of having significant underlying CAD. We have therefore
shown the relative likelihood ratios of the perfusion
component as the starting point, and building on this
using selected combinations as “add on” tests, highlight-
ing the number of new true and false positive cases
produced by each combination (Table 5). This analysis
showed that no add on test to perfusion imaging is
preferable for ruling in the diagnosis (since all add on
tests reduce the relative LR+), but adding on compo-
nents can improve the rule-out value of the CMR exam-
ination (all add on tests reduce the LR-).
Comparative literature
There have been a number of other studies analysing the
diagnostic performance of the components of the CMR
examination, although none of this magnitude and many
of which being performed in highly selected populations.
Table 3 Diagnostic accuracy of a multi-parametric CMR exam and its individual components, paired and triplet combinations
compared to the reference test X-ray angiography
Sensitivity (95 % CI) Specificity (95 % CI) PPV (95 % CI) NPV (95 % CI) Overall accuracy (95 % CI)
Overall multi-parametric CMR study
(all components) (n = 676)
86.5 (81.8, 90.1) 83.4 (79.5, 86.7) 77.2 (72.1, 81.6) 90.5 (87.1, 93.0) 84.6 (81.7, 87.1)
Individual CMR components
LGE (n = 674) 40.8 (35.0, 46.8) 95.8 (93.4, 97.4) 86.4 (79.3, 91.3) 71.4 (67.5, 75.0) 74.2 (70.7, 77.3)
Perfusion (n = 661) 76.9 (71.4, 81.6) 91.8 (88.7, 94.1) 85.8 (80.8, 89.7) 86.0 (82.4, 89.0) 85.9 (83.1, 88.4)
Ventricular function (n = 676) 47.4 (41.4, 53.4) 93.7 (90.9, 95.6) 82.9 (76.1, 88.1) 73.3 (69.3, 76.9) 75.4 (72.1, 78.5)
MRA (n = 597) 71.2 (65.1, 76.7) 89.8 (86.3, 92.5) 81.8 (75.9, 86.5) 83.0 (79.0, 86.4) 82.6 (79.3, 85.4)
Paired combinations
Perfusion/LGE (n = 676) 78.6 (73.3, 83.1) 89.3 (85.9, 91.9) 82.6 (77.5, 86.8) 86.5 (82.9, 89.5) 85.1 (82.2, 87.5)
Perfusion/function (n = 676) 80.1 (74.9, 84.4) 87.3 (83.7, 90.2) 80.4 (75.2, 84.7) 87.1 (83.5, 90.0) 84.5 (81.5, 87.0)
Perfusion/MRA (n = 676) 82.3 (77.3, 86.4) 89.0 (85.6, 91.7) 83.0 (78.0, 87.0) 88.6 (85.2, 91.3) 86.4 (83.6, 88.8)
Function/LGE (n = 676) 52.6 (46.6, 58.6) 91.7 (88.6, 94.0) 80.5 (73.9, 85.7) 74.9 (70.9, 78.5) 76.3 (73.0, 79.4)
Function/MRA (n = 676) 72.9 (67.3, 77.9) 87.8 (84.3, 90.6) 79.5 (74.0, 84.1) 83.3 (79.5, 86.6) 82.0 (78.9, 84.7)
LGE/MRA (n = 676) 69.2 (63.4, 74.4) 90.0 (86.7, 92.5) 81.8 (76.2, 86.3) 81.8 (78.0, 85.1) 81.8 (78.7, 84.5)
Triplet combinations
Perfusion/LGE/function (n = 676) 81.6 (76.5, 85.8) 85.9 (82.1, 88.9) 78.9 (73.7, 83.3) 87.8 (84.2, 90.6) 84.2 (81.2, 86.7)
Perfusion/LGE/MRA (n = 676) 84.6 (79.8, 88.4) 86.6 (82.9, 89.5) 80.4 (75.3, 84.6) 89.6 (86.3, 92.3) 85.8 (83.0, 88.2)
Perfusion/function/MRA (n = 676) 85.3 (80.6, 89.1) 84.9 (81.1, 88.0) 78.5 (73.5, 82.9) 89.9 (86.5, 92.5) 85.1 (82.2, 87.5)
LGE/function/MRA (n = 676) 75.2 (69.7, 80.0) 86.1 (82.4, 89.1) 77.8 (72.4, 82.5) 84.2 (80.5, 87.4) 81.8 (78.7, 84.5)
CMR cardiovascular magnetic resonance, LGE late gadolinium enhancement, LR- Likelihood Ratio Negative, LR+ Likelihood Ratio Positive, MRA magnetic resonance
coronary angiography
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One study analysed the diagnostic accuracy of CMR
components in 100 patients preselected for X-ray coron-
ary angiography (≥70 % stenosis as the reference stand-
ard) [8]. The CMR protocol included wall motion, stress
and rest perfusion and LGE. The analysis algorithm con-
sidered LGE images first with presence of severe CAD
diagnosed if LGE was positive in an ischaemic pattern. If
LGE was negative the perfusion images were analysed
and a reversible defect used to diagnose CAD. This
analysis algorithm had a sensitivity (89 %) and specificity
(87 %) - which was similar to the CE-MARC study. In
terms of individual components compared to CE-
MARC, the perfusion component in this previous study
had the highest sensitivity (84 % vs. 77 % in our
Fig 1 Diagnostic accuracy of the individual components and their combinations compared to the full multi-parametric CMR examination.
Cine – Cine imaging; LGE – late gadolinium enhancement; Perf –perfusion imaging; MRA – magnetic resonance coronary angiography
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population) although with a significantly lower specifi-
city (58 % vs. 92 %). Wall motion scoring was not
considered in their analysis algorithm; cine images were
acquired and had a similar sensitivity (49 % vs. 47 %) but
lower specificity (73 % vs. 94 %) than in our study.
In patients with non ST-segment elevation myocardial
infarction our group has previously evaluated the diag-
nostic accuracy of all 4 components of the CMR exam-
ination, performed within 72 h of presentation, with an
overall sensitivity of 96 %, specificity 83 %, PPV 96 %
and NPV 83 % [9]. Once again the perfusion component
of the examination yielded the highest sensitivity (88 %),
although in this study it was higher than when com-
pared to our stable elective population (77 %).
Cury et al. studied a mixed cohort of 47 patients (14
with previous MI) and also demonstrated that stress
perfusion imaging had the highest sensitivity (81 %) and
LGE the highest specificity (94 %) [10]. The maximum
diagnostic accuracy was achieved with the combination
of stress perfusion and LGE, and unsurprisingly this was
again higher in the sub-group of patients with previous
myocardial infarction than those with suspected CAD
and no prior infarction (93 % vs. 86 %).
The clinical utility of imaging coronary artery anat-
omy with dedicated coronary MRA protocols in expert
centres has been demonstrated to have good diagnostic
accuracy for the detection of proximal CAD [14]. Tech-
nical advances at 3.0 Tesla and using a 32 channel coil
have been shown to further improve signal to noise ra-
tio and overall accuracy compared with initial reports,
yielding sensitivities of 92-96 % [15, 16]. However, the
efficacy of coronary imaging within a combined CMR
protocol remains to be established. Klein et al. per-
formed coronary MRA, stress and rest perfusion and
LGE imaging on 54 patients with suspected CAD, again
showing the perfusion component was the most accur-
ate alone (sensitivity 87 %, specificity 88 %). They
showed that the addition of LGE to stress perfusion im-
aging did not improve the overall diagnostic accuracy
(sensitivity 88 %, specificity 88 %). In terms of coronary
imaging, 15 % of overall MRA had non-diagnostic
image quality; whole heart MRA had significantly infer-
ior diagnostic accuracy due to poor specificity (sensitiv-
ity 92 %, specificity 56 %) unless only those with
excellent MRA image quality (n = 18, 33 %) were ana-
lysed, whereupon it remained similar to the perfusion
component alone (sensitivity 86 %, specificity 91 %)
[11]. Other investigators have evaluated the effect of
adding coronary MRA to stress perfusion CMR on
diagnostic performance; when compared to invasive
pressure-wire derived fractional flow reserve (FFR) at
1.5 T there was no significant improvement in diagnos-
tic accuracy [12].
Table 4 Likelihood ratios positive and negative for the
multi-parametric CMR exam and its individual components,
paired and triplet combinations compared to the reference test
X-ray angiography
Likelihood
ratio + ve (95 % CI)
Likelihood
ratio –ve (95 % CI)
Overall multi-parametric CMR
study (all components) (n = 676)
5.21 (4.17, 6.51) 0.16 (0.12, 0.22)
Individual CMR components
LGE (n = 674) 9.81 (6.02, 15.97) 0.62 (0.56, 0.68)
Perfusion (n = 661) 9.35 (6.70, 13.05) 0.25 (0.20, 0.31)
Ventricular function (n = 676) 7.47 (5.04, 11.07) 0.56 (0.50, 0.63)
MRA (n = 597) 7.01 (5.11, 9.61) 0.32 (0.26, 0.39)
Paired combinations
Perfusion/LGE (n = 676) 7.32 (5.50, 9.75) 0.24 (0.19, 0.30)
Perfusion/function (n = 676) 6.31 (4.86, 8.20) 0.23 (0.18, 0.29)
Perfusion/MRA (n = 676) 7.50 (5.66, 9.94) 0.20 (0.15, 0.26)
Function/LGE (n = 676) 6.35 (4.51, 8.93) 0.52 (0.45, 0.59)
Function/MRA (n = 676) 5.98 (4.57, 7.83) 0.31 (0.25, 0.38)
LGE/MRA (n = 676) 6.92 (5.12, 9.35) 0.34 (0.29, 0.41)
Triplet combinations
Perfusion/LGE/function (n = 676) 5.77 (4.51, 7.37) 0.21 (0.17, 0.28)
Perfusion/LGE/MRA (n = 676) 6.31 (4.90, 8.11) 0.18 (0.13, 0.24)
Perfusion/function/MRA (n = 676) 5.64 (4.46, 7.14) 0.17 (0.13, 0.23)
LGE/function/MRA (n = 676) 5.41 (4.21, 6.95) 0.29 (0.23, 0.36)
Table 5 Relative likelihood ratios and the numbers of new true positive and false positive cases produced by adding on further
components sequentially to stress perfusion imaging in isolation
Relative LR+ Relative LR- New true positive cases produced New false positives cases produced
Perfusion (+LGE) 0.78 0.91 7 11
Perfusion (+function) 0.68 0.89 9 18
Perfusion (+MRA) 0.79 0.76 16 12
Perfusion + LGE (+function) 0.79 0.89 8 14
Perfusion + LGE (+MRA) 0.86 0.74 16 11
Perfusion + function (+MRA) 0.89 0.76 14 10
Perfusion + function (+LGE) 0.91 0.94 4 6
LGE late gadolinium enhancement, LR likelihood ratio, MRA magnetic resonance coronary angiography
Ripley et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:59 Page 7 of 9
Coronary MRA remains a time consuming acquisition,
which often is non-diagnostic when performed within an
already long multi-parametric protocol. In our study 79
patients (11.7 %) had non-diagnostic coronary MRA
images. Furthermore, in those with adequate or excellent
image quality (n = 597), the addition of the coronary
MRA made no difference statistically on the overall
diagnostic accuracy of the CMR examination. Equally,
whilst some triplet combinations with MRA offer similar
diagnostic accuracy, the components of cine, LGE and
perfusion imaging offer clinical information above and
beyond detection of coronary disease (i.e., left ventricu-
lar volumes/ejection fraction, myocardial viability and
ischaemic burden) which may have additional prognostic
importance.
Conclusions
From this pre-specified sub-analysis of the CE-MARC
study, using the original blinded visual-read, we have
demonstrated the diagnostic accuracy of the individual
components and their combinations from the full multi-
parametric CMR exam. In patients presenting with stable
chest pain, the stress perfusion component of the
multi-parametric CMR exam was the single most import-
ant component for overall diagnostic accuracy. However,
the full combined multi-parametric protocol was the opti-
mal approach for disease rule-out, and the LGE compo-
nent best for rule-in. The inclusion of coronary MRA had
no additional overall diagnostic benefit within a multi-
parametric protocol.
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